გამოგვყევი
GE
GE

Life4me+-ის ერთ-ერთი მთავარი მიზანია აივ, სხვა სგგი, ჰეპატიტი C და ტუბერკულოზის ახალი შემთხვევების პრევენცია.

აპლიკაცია ეხმარება აივ დადებით პირებს ექიმებთან ანონიმური კომუნიკაციის დამყარებაში. ეს ყველაფერი დაგეხმარებათ ორგანიზება გაუკეთოთ მედიკამენტების მიღების განრიგს და დააყენოთ ფარული და პერსონალიზებული შეხსენებები.

ყველა სიახლე

არქივი

✕
9 ოქტომბერი 2017
5897
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Inc. today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1.
9 ოქტომბერი 2017
7509
Gay Men May Be Able to Self-Check for Anal Cancer

Gay Men May Be Able to Self-Check for Anal Cancer

A recent study found that self- and partner exams were a fairly reliable way of identifying anal abnormalities that may be signs of cancer.
9 ოქტომბერი 2017
6792
ART Limits Appropriate Contraceptive Options for Women with HIV

ART Limits Appropriate Contraceptive Options for Women with HIV

Hormonal contraceptives with potential drug-drug interactions with antiretroviral therapy are commonly prescribed to women living with HIV, according to retrospective study findings.
8 ოქტომბერი 2017
6950
How UNAIDS “90-90-90” target looks in Russia today

How UNAIDS “90-90-90” target looks in Russia today

According to the Federal AIDS Center estimates, the UNAIDS "90-90-90" target in Russia looks like "64-33-75".
6 ოქტომბერი 2017
5770
Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare (e. g. mobile apps or websites) have a number of positive effects to people living with HIV
6 ოქტომბერი 2017
6077
Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIVSince the advent of effective combination antiretroviral treatment two decades ago, the risk of many cancers has fallen for people living with HIV. However, this population’s risk for a slew of cancers remains elevated ...
4 ოქტომბერი 2017
6607
New approach: Lock HIV in reservoir cells, to die through apoptosis

New approach: Lock HIV in reservoir cells, to die through apoptosis

Researchers at Kumamoto University developed a new approach that they call "Lock-in and apoptosis." First, they synthesized the compound L-HIPPO, which binds strongly to the HIV protein Pr55Gag and suppresses viral budding. When L-HIPPO was added to virus-infected cells ...
4 ოქტომბერი 2017
7047
HIV-related stigma is preventing people from accessing HIV services

HIV-related stigma is preventing people from accessing HIV services

UNAIDS has released a new report showing how stigma and discrimination is creating barriers to accessing HIV prevention, testing and treatment services and putting lives at risk.
4 ოქტომბერი 2017
6279
Maraviroc-Containing PrEP Regimens Found to be Safe in Women

Maraviroc-Containing PrEP Regimens Found to be Safe in Women

The study showed that MVC-containing anti-retroviral regimens were generally safe and well-tolerated in a female population, compared with a TDF-FTC regimen. These results are similar to those reported earlier by the same group of cohorts in men and provide evidence that ...
3 ოქტომბერი 2017
6662
Decline in new HIV diagnoses in gay and bisexual men in London

Decline in new HIV diagnoses in gay and bisexual men in London

In 2016, 5,164 people were newly diagnosed with HIV in the United Kingdom, representing an 18% decline from the 6,286 diagnoses reported in 2015. The decrease was most apparent in gay and bisexual men. In this group, the number of HIV diagnoses reported steadily increased ...
ჩვენ ვიყენებთ ქუქის, რათა გავაუმჯობესოთ თქვენ მიერ საიტის მოხმარება
ვებ-გვერდზე ნებისმიერ ღილაკზე დაჭერით თქვენ გვაძლევთ უფლებას, რომ გამოვიყენოთ თქვენი cookies.